| CAS: | 861891-50-1 | |||
| 分子式: | C19H23N3O2 | |||
| 分子量: | 325.4 | |||
| 英文名称: |
| |||
| 用途: | IM-54 is an indolylmaleimide derivative which, at 1 μM, inhibits necrotic cell death induced by H2O2 in promyelocytic leukemia HL-60 cells. |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||
| I912864 | MACKLIN | IM-54 | 98% | 833元/5mg; 3536元/25mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||
储存:-20°C,密闭,干燥 状态:浅黄色到浅橙色到橙色到暗橙色粉末 | |||||||||||||||||||||||||||||||||||||||||||
| 480060 | Sigma-Aldrich | Necrosis Inhibitor, IM-54-CAS 861891-50-1-Calbiochem | The Necrosis Inhibitor, IM-54, also referenced under CAS 861891-50-1, selectively blocks oxidative stress-induced necrotic cell death. This small molecule/inhibitor is primarily used for Cancer applic | 3247.82元/5 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A cell-permeable mono-indolylmaleimide compound that selectively blocks oxidative stress-induced necrotic cell death (~3 µM IM-54 prevented ~50% cell death in HL60 cells exposed to 100 µM H2O2). Does not offer protection against Etoposide- (Cat. No. 341205) induced apoptosis or display antioxidant properties. Does not affect the kinase activities of S6K1 and PKC isozymes even at concentrations as high as 50 µM. 包装 5 mg in Glass bottle 生化/生理作用 Cell permeable: yes 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C. 其他说明 Dodo, K., et al. 2005. Bioorg. Med. Chem. Lett.15, 3114. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||
| SML0412 | Sigma-Aldrich | IM-54 | ≥98% (HPLC) | 1850.48元/5 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 IM-54 is a cell permeable, potent and selective inhibitor of necrosis. The compound inhibits necrosis induced by oxidative stress. IM-54 does not inhibit apoptosis induced by anticancer drugs. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||